The DOI matches its Crossref record.
Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal
Abstract
Deposits of amyloid beta-peptide (A beta), reduced glucose uptake into brain cells, oxidative damage to cellular proteins and lipids, and excitotoxic mechanisms have all been suggested to play roles in the neurodegenerative process in Alzheimer's disease. Synapse loss is closely correlated with cognitive impairments in Alzheimer's disease, suggesting that the synapse may be the site at which degenerative mechanisms are initiated and propagated. We report that A beta causes oxyradical-mediated impairment of glucose transport, glutamate transport, and mitochondrial function in rat neocortical synaptosomes. A beta induced membrane lipid peroxidation in synaptosomes that occurred within 1 h of exposure; significant decreases in glucose transport occurred within 1 h of exposure to A beta and decreased further with time. The lipid peroxidation product 4-hydroxynonenal conjugated to synaptosomal proteins and impaired glucose transport; several antioxidants prevented A beta-induced impairment of glucose transport, indicating that lipid peroxidation was causally linked to this adverse action of A beta. FeSO4 (an initiator of lipid peroxidation), A beta, and 4-hydroxynonenal each induced accumulation of mitochondrial reactive oxygen species, caused concentration-dependent decreases in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction, and reduced cellular ATP levels significantly. A beta also impaired glutamate transport, an effect blocked by antioxidants. These data suggest that A beta induces membrane lipid peroxidation, which results in impairment of the function of membrane glucose and glutamate transporters, altered mitochondrial function, and a deficit in ATP levels; 4-hydroxynonenal appears to be a mediator of these actions of A beta. These data suggest that oxidative stress occurring at synapses may contribute to the reduced glucose uptake and synaptic degeneration that occurs in Alzheimer's disease patients. They further suggest a sequence of events whereby oxidative stress promotes excitotoxic synaptic degeneration and neuronal cell death in a variety of different neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A variety of in vitro investigations have revealed that mitochondria have reduced membrane potential, increased permeability, increased ROS production, altered trafficking, and aberrant fission/fusion regulation when exposed to A (Keller et al., 1997;Mattson et al., 1998; Abramov et al., 2004;Lustbader et al., 2004;Manczak et al., 2006;Wang et al., 2008;Reddy, 2009;Calkins et al., 2011;Manczak et”
From Mitochondrial alterations near amyloid plaques in an Alzheimer’s disease mouse model (2013) · cites this paper as Keller et al., 1997
Citations
Cited by
Sorted by citations
Items 301–400 of 440
Bamji‐Mirza, M., Callaghan, D., Najem, D., Shen, S., Hasim, M. S., Yang, Z., & Zhang, W. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131949 · Cited by 26
“Short term exposure of A to cerebral synaptosomes from Sprague-Dawley rats resulted in lipid peroxidation and a significant decrease in glucose transport [7] suggesting that impairments in insulin signaling and glucose utilization occur during the early stages of AD, prior to significant A plaque burden.”
BackgroundAkang, E. N., Dosumu, O. O., Afolayan, O. O., Fagoroye, A. M., Osiagwu, D. D., Usman, I. T., Oremosu, A. A., & Akanmu, S. A. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.04.002 · Cited by 26
“It has been reported that the byproducts of lipid peroxidation have high affinity for amino acids, hampering glutamate and sugar uptake blocking neurotransmitters and activating c-Jun and MAP kinase pathways to invoke cellular apoptosis (Keller et al., 1997).”
BackgroundActivation of phosphatidylcholine signalling during oxidative stress in synaptic endings
Mateos, M. V., Uranga, R. M., Salvador, G. A., & Giusto, N. M. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.07.005 · Cited by 26
“The methods employed in the present study are similar to those described by Keller and co workers (Keller et al., 1997a,b).”
Membrane Disordering Effects of β-Amyloid Peptides
Eckert, G. P., Wood, W. G., & Müller, W. E. G. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_16 · Cited by 26
Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease
Seike, T., Chen, C., & Mochly‐Rosen, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1223977 · Cited by 28
“4-HNE leads to dysfunction of glucose and glutamate transporters, mitochondrial dysfunction, and reduced adenosine triphosphate (ATP) levels, and is involved in synaptic degeneration (Keller et al., 1997).”
BackgroundPrapong, T., Uemura, E., & Hsu, W. H. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7519 · Cited by 25
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Yip, J., Chiang, G. S. H., Lee, I. C. J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L. Y.-T., Teo, D. W. X., Seah, G. T., & Lehming, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010364 · Cited by 30
Cellular mechanisms of brain hypoglycemia
Исаев, Н. К., Stelmashook, E. V., & Zorov, D. B. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907050021 · Cited by 24
Diabetes, Insulin and Alzheimer's Disease
Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24
Metabolic regulation of aging and age-related disease
Hamrick, M. W., & Stranahan, A. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101175 · Cited by 27
From the Mind to the Spine: The Intersecting World of Alzheimer’s and Osteoporosis
Margetts, T. J., Wang, H. S., Karnik, S. J., Plotkin, L. I., Movilă, A., Oblak, A. L., Fehrenbacher, J. C., & Kacena, M. A. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00848-w · Cited by 26
“Oxidative damage has been implicated in the impairment of glucose and glutamate transport and mitochondrial dysfunction induced by Aβ in synaptosomes [119].”
BackgroundMiyake, H., Kadoya, A., & Ohyashiki, T. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1652 · Cited by 23
Mutant presenilin 2 increased oxidative stress and p53 expression in neuronal cells
Nguyen, H. N., Lee, M. S., Hwang, D. Y., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.119 · Cited by 22
Brain Damage - Bridging Between Basic Research and Clinics
González-Quevedo, A. (2012) · InTech eBooks · doi:10.5772/2174 · Cited by 21
Duarte, A. I., Santos, M. S., Seiça, R. M. F., & Oliveira, C. R. (2000) · Neuroendocrinology · doi:10.1159/000054585 · Cited by 21
Distinct Glycolysis Inhibitors Determine Retinal Cell Sensitivity to Glutamate-Mediated Injury
Rego, A. C., Areias, F. M., Santos, M. S., et al. (1999) · Neurochemical Research · doi:10.1023/a:1020977331372 · Cited by 21
Naproxen-induced oxidative stress in the isolated perfused rat liver
Yokoyama, H., Horie, T., & Awazu, S. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.01.003 · Cited by 21
Lomoio, S., Scherini, E., & Necchi, D. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.052 · Cited by 20
Oxidative Alterations in Neurodegenerative Diseases
Markesbery, W. R., Montine, T. J., & Lovell, M. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_2 · Cited by 27
“impairing the function of, membrane ion-motive ATPases, glucose transporters, and glutamate transporters (Mark et al., 1995, 1997a, b; Keller et al., 1997).”
BackgroundInfluence of vitamin E succinate on retinal cell survival
Rego, A. C., Santos, M. S., Proença, M. T., et al. (1998) · Toxicology · doi:10.1016/s0300-483x(98)00054-7 · Cited by 20
“…of the retinal cells submitted to vitamin E succinate supplementation was analyzed by the release of LDH, which is indicative of irreversible membrane disruption and cell death, and by the reduction of MTT, suggested to be a measure of the mitochondria activity (Mosmann, 1983; Keller et al., 1997).”
BackgroundMethodInfluentialJia, Y., Wang, W., Han, N., Sun, H.-L., Dong, F., Song, Y., Feng, R.-F., & Wang, J.-H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.02.076 · Cited by 19
Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer’s Disease and Osteoporosis
Wang, H. S., Karnik, S. J., Margetts, T. J., Plotkin, L. I., Movilă, A., Fehrenbacher, J. C., Kacena, M. A., & Oblak, A. L. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00851-1 · Cited by 24
Stranahan, A. M., Lee, K. M., & Mattson, M. P. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2007.12.004 · Cited by 19
Self-citationSrivastava, S., Pant, A., Trivedi, S., et al. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.01.001 · Cited by 19
Ou, J. J., Zhang, Y., & Montine, T. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7923 · Cited by 19
4-Hydroxynonenal disrupts zinc export in primary rat cortical cells
SMITH, J., Xiong, S., & Lovell, M. A. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.05.009 · Cited by 19
Tenório, T. D. S., Silva, A. M., Ramos, J. M., Buarque, C. D., & Felcman, J. (2012) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2012.12.019 · Cited by 18
Gupta, S., Upadhayay, D., Sharma, U., Jagannathan, N. R., & Gupta, Y. K. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24226 · Cited by 18
“Lipid peroxidation is also reported to induce apoptosis by generation of 4-hydroxynonenal, which impairs the functioning of membrane transporters such as Na(1) ATPase, K(1) ATPase, glucose, and Glu (Keller et al., 1997).”
BackgroundPerone, I., Ghena, N., Wang, J., Mackey, C. D., Wan, R., Malla, S., Gorospe, M., Cheng, A., & Mattson, M. P. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08713-2 · Cited by 20
“Data from studies of cultured neurons and transgenic mice that develop Aβ plaques have shown Aβ aggregation on neuronal membranes where the Aβ impairs the function of ion-motive ATPases and glucose transporters, rendering neurons vulnerable to cellular calcium overload, and excitotoxicity (Keller et al., 1997; Mark et…”
BackgroundSelf-citationJia, K., Tian, J., Wang, T., Guo, L., Xuan, Z., Swerdlow, R. H., & Du, H. (2023) · JCI Insight · doi:10.1172/jci.insight.174290 · Cited by 20
Bo, X., Mu, D., Wu, M., Xiao, H., & Wang, H. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.01.027 · Cited by 16
Role of Metals in Neuronal Apoptosis: Challenges Associated with Neurodegeneration
Ravid, R., & Rao, K. S. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249399 · Cited by 18
Ji, B., Ito, K., & Horie, T. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034067m · Cited by 17
Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases
Wang, L., Fang, X., Ling, B., Wang, F., Xia, Y., Zhang, W., Zhong, T., & Wang, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1359453 · Cited by 18
Begley, J. G., Butterfield, D. A., Keller, J. N., et al. (1998) · Brain Research Protocols · doi:10.1016/s1385-299x(98)00024-5 · Cited by 16
Self-citationSchiekofer, S., Rudofsky, G., Andrassy, M., Schneider, J. G., Chen, J., Isermann, B., Kanitz, M., Elsenhans, S., Heinle, H., Balletshofer, B. M., et al. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00270.x · Cited by 16
Excitatory amino acid transporters as emerging targets for central nervous system therapeutics
Dunlop, J., Zaleska, M. M., Eliasof, S. D., & Moyer, J. A. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.4.543 · Cited by 16
Estrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer
Manzano‐León, N., & Mas‐Oliva, J. (2006) · Gaceta Médica de México · Cited by 16
Fowler, C. J., Ando, Y., & Tiger, G. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00013-8 · Cited by 15
Lieb, I., Chebib, M., Cooper, B., Dias, L. S., & Balcar, V. J. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00140-0 · Cited by 15
REMOVED: Protein kinase inhibitors in traumatic brain injury and repair: New roles of nanomedicine
Sharma, H. S., Sahib, S., Tian, Z. R., Muresanu, D. F., Nozari, A., Lafuente, J. V., Wiklund, L., & Sharma, A. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.09.009 · Cited by 14
Pereira, C., Moreira, P. I., Seiça, R. M. F., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7270 · Cited by 14
Lauderback, C. M., Breier, A. M., Hackett, J. M., Varadarajan, S., Goodlett-Mercer, J., & Butterfield, D. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00015-6 · Cited by 13
Glutamate Receptors in Aging and Alzheimer's Disease
Mishizen-Eberz, A. J., Ikonomović, M. D., & Armstrong, D. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50022-6 · Cited by 18
4-Hydroxyhexenal (HHE) Impairs Glutamate Transport in Astrocyte Cultures
Lovell, M. A., Bradley‐Whitman, M. A., & Fister, S. X. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120409 · Cited by 15
“modified by exposure to A [25, 35, 63–66] or alde-”
Assemblages of prion fragments: novel model systems for understanding amyloid toxicity
Satheeshkumar, K., Murali, J., & Rajadas, J. (2004) · Journal of Structural Biology · doi:10.1016/j.jsb.2004.05.006 · Cited by 13
Chakraborty, S., & Basu, S. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1081-2 · Cited by 11
“exposure of synapses to Ab impairs the function of membrane ion channels, glutamate transporters, and compromises mitochondrial function mediated by oxidative stress (Keller et al., 1997).”
BackgroundPrevention and Therapy of Neurodegenerative Disorders: Role of Nutritional Antioxidants
Matteo, V. D., Pierucci, M., Giovanni, G. D., & Esposito, E. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50168-x · Cited by 11
Cruz, F., & Wolf, A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00642-6 · Cited by 10
Lemon, J. A., Aksenov, V., Samigullina, R., Aksenov, S., Rodgers, W. H., Rollo, C. D., & Boreham, D. R. (2016) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22019 · Cited by 12
Yun, Z., Takagi, M., & Yoshida, T. (2003) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(03)90097-1 · Cited by 10
Mechanisms and Prevention of Noise-Induced Hearing Loss
Miller, J. M., Yamashita, D., Minami, S., Yamasoba, T., & Prell, C. G. L. (2006) · Otology Japan · doi:10.11289/otoljpn1991.16.139 · Cited by 9
The role of mitochondrial uncoupling in the regulation of mitostasis after traumatic brain injury
Hubbard, W. B., Velmurugan, G. V., & Sullivan, P. G. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105680 · Cited by 10
Adventures in Neural Plasticity, Aging, and Neurodegenerative Disorders Aboard the CWC Beagle
Mattson, M. P. (2003) · Neurochemical Research · doi:10.1023/a:1026000703290 · Cited by 8
Self-citationZhang, D., Jin, B., Ondrejčák, T., & Rowan, M. J. (2016) · Hippocampus · doi:10.1002/hipo.22667 · Cited by 8
“Reducing glutamate receptor activation with receptor antagonists (Hu et al., 2009; Klyubin et al., 2011; Rammes et al., 2011; Ronicke et al., 2011; Hu et al., 2014), or by enhancing glutamate clearance (Li et al., 2009; Takahashi et al., 2015; Varga et al., 2015; Zumkehr et al., 2015) has been…”
BackgroundAdaptative responses of spinal astrocytes to oxidative stress
Cassina, P., Peluffo, H., & Barbeito, L. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32092-7 · Cited by 8
Chapter 9 The Role of Mitochondrial Genome Mutations in Neurodegenerative Disease
Glazner, G. W. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60029-2 · Cited by 7
Oxidation of 4-hydroxynonenal in rat brain slices
Murphy, T. C., Amarnath, V., & Picklo, M. J. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00182-5 · Cited by 7
Polansky, H., & Goral, B. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-01012-9 · Cited by 9
“With an increased oxidative stress, energy metabolism is impaired, eventually leading to neuronal damage, neurodegeneration pathologies, and AD (Keller et al. 1997; Manczak et al. 2006).”
BackgroundOxidative and Inflammatory Properties of Aluminum: Possible Relevance in Alzheimer’s Disease
Bondy, S. C., & Campbell, A. (2001) · Elsevier eBooks · doi:10.1016/b978-044450811-9/50041-0 · Cited by 7
Cholinergic Neurotransmission, Amyloid-β Peptide and the Pathogenesis of Alzheimer's Disease
Liu, L. (2003) · Cited by 7
Synaptic-mitochondrial transport: mechanisms in neural adaptation and degeneration
Ding, Y., Yang, H., Gao, J., Tang, C. L., Peng, Y.-Y., Ma, X., Li, S., Wang, H., Lu, X., & Wang, Y. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05209-y · Cited by 7
The Unified Theory of Neurodegeneration Pathogenesis Based on Axon Deamidation
Joseph, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094143 · Cited by 6
“According to Keller et al. [116], HNE disrupts glucose and glutamate transport by impairing the glucose transporter type-3 and glutamate transporter 1 (GLT-1).”
Sahib, S., Sharma, A., Muresanu, D. F., Zhang, Z., Li, C., Tian, Z. R., Buzoianu, A. D., Lafuente, J. V., Nozari, A., Patnaik, R., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.06.007 · Cited by 6
Expression of chaperonin 60 in the hippocampus of the streptozotocin diabetic rat
Yuan, J., Young, B. J., & Martinus, R. D. (2006) · Neuroreport · doi:10.1097/01.wnr.0000201503.15632.06 · Cited by 6
“Such increases produce impaired mitochondrial function in brain synaptosomes [13], and more generally, exacerbate oxidative stress, mitochondrial dysfunction and neuronal death [14].”
BackgroundManzoor, S., Ayesha, K., Hasan, B., Mushtaq, S., & Ahmed, N. (2021) · Current Proteomics · doi:10.2174/1570164618666210121151004 · Cited by 5
Han, N., Kim, Y. J., Park, S. M., Kim, S. M., Lee, J., Jung, H. S., Lee, E. J., Kim, T. K., Kim, T. N., Kwon, M. J., et al. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.5.396 · Cited by 5
“Amyloid β-peptidecaused Alzheimer’s disease inhibits glucose transport, which in turn triggers the glucose deprivation apoptotic cascade in the cortex and hippocampus [27,28].”
BackgroundMolecular Mechanisms of Acute Brain Injury and Ensuing Neurodegeneration
Francisco, J., Jose, M., Mahy, N., & Manuel, J. (2012) · InTech eBooks · doi:10.5772/37401 · Cited by 5
Preserving Function in Acute Nervous System Injury
Hall, E. D., & Sullivan, P. G. (2005) · Elsevier eBooks · doi:10.1016/b978-012738903-5/50004-7 · Cited by 5
Analysis of HNE metabolism in CNS models
Kubátová, A., Honzátko, A., Brichac, J., et al. (2007) · Redox Report · doi:10.1179/135100007x162149 · Cited by 5
Effect of Glucose Deprivation and Acute Glutamate Exposure in Cultured Retinal Cells
Rego, A. C., Areias, F. M., Santos, M. S., et al. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6865 · Cited by 5
“1) and a decrement in the cellular redox efficacy, probably related with changes in mitochondrial function (11, 16), as determined by the MTT method (Table 1).”
MethodRahman, M. M., Islam, M. R., Tumpa, M. A. A., Shohag, S., shuvo, S. K., Ferdous, J., Kajol, S. A., Aljohani, A. S. M., Abdulmonem, W. A., Rauf, A., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110375 · Cited by 4
Free Radicals and Neuroprotection in Traumatic Brain and Spinal Cord Injury
Hall, E. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_10 · Cited by 4
Inflammation, Free Radicals, Glycation, Metabolism and Apoptosis, and Heavy Metals
Mattson, M. P. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50025-1 · Cited by 5
Self-citationStructure, function and regulation of glutamate transporters
Levy, L. M. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.pt5 · Cited by 4
Oxidative Stress and Metals in Alzheimer’s Disease
Fathima, S. A., Maurya, R., & Naqvi, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_2 · Cited by 5
Carbonyl Stress, Aging Mechanisms, and The Up-stream Molecular Etiology of Alzheimer′s Disease*
Yin, D., & Liu, W. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00316 · Cited by 3
Insulin-Mediated Neuroplasticity in the Central Nervous System
Reagan, L. P. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_3 · Cited by 3
“In this regard, the glial glutamate transporter GLT-1 is a target of HNE protein conjugation, which may be responsible for HNE-mediated decreases in glutamate transport in primary astrocytic cultures (Blanc et al. 1998) and in rat cortical synaptosomal fractions ( Keller et al. 1997 ).”
BackgroundWolkow, C. A., Zou, S., & Mattson, M. P. (2009) · Springer eBooks · doi:10.1007/978-90-481-3465-6_14 · Cited by 3
Self-citationAddressing the Complex Etiology of Alzheimer‘s Disease: the Role of P25/Cdk5
Mungenast, A. E., & Tsai, L. (2011) · Future Neurology · doi:10.2217/fnl.11.22 · Cited by 3
Beckert, B., Acker‐Palmer, A., & Volknandt, W. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0238 · Cited by 3
Tenório, T. D. S., & Tenório, A. (2015) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2015.06.005 · Cited by 3
Perrin, F., Anderson, L. C., Mitchell, S. P. C., Sinha, P., Turchyna, Y., Maesako, M., Houser, M. C., Zhang, C. M., Wagner, S. L., Tanzi, R. E., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01876-y · Cited by 6
Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders
Keller, J. N., & Glazner, G. W. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)07020-1 · Cited by 2
Self-citationExperimental and theoretical investigation of [Al(PCr)(H2O)] complex in aqueous solution
Tenório, T. D. S., Lopes, D. C. N., Silva, A. M., Ramos, J. M., & Buarque, C. D. (2013) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2013.08.073 · Cited by 2
Role of Nutritional Antioxidants in the Prevention and Treatment of Neurodegenerative Disorders
Esposito, E. (2006) · Nutrition and disease prevention · doi:10.1201/9781420019131.ch5 · Cited by 2
Overview: Membrane lipid peroxidation
Montine, K. S., Quinn, J. F., & Montine, T. J. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)12002-0 · Cited by 2
Mattson, M. P., Pedersen, W. A., & Culmsee, C. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_6 · Cited by 2
Self-citationGlutamate regulates the viability of retinal cells in culture
Rego, A. C., Santos, M. S., Areias, F. M., et al. (2001) · Vision Research · doi:10.1016/s0042-6989(00)00309-6 · Cited by 2
In Vivo Imaging of Alzheimer Pathology in Transgenic Mice using Multiphoton Microscopy
Bacskai, B. J., Klunk, W. E., Hickey, G. A., Skoch, J. M., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Debnath, M. L., Holt, D. P., Wang, Y., et al. (2004) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-59300-0_4 · Cited by 2
Contribution of Dietary Carbohydrates in Induction of Oxidative Stress
Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_8 · Cited by 2
Hoyer, S., & Frölich, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_12 · Cited by 2
Oxidative stress in neurodegenerative diseases
Javaid, M., Arain, F. M., & Javaid, M. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18807-7.00011-9 · Cited by 2
The role of ALDH2 rs671 polymorphism and C-reactive protein in the phenotypes of male ALS patients
Huang, L., Liu, M., Tang, J., Gong, Z., Li, Z., Yang, Y., & Zhang, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1397991 · Cited by 1
The Aβcentric Pathway of Alzheimer’s Disease
Villemagne, V. L., Cappai, R., Barnham, K. J., Cherny, R. A., Opazo, C., Novakovic, K. E., Rowe, C. C., & Masters, C. L. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_2 · Cited by 4
Pharmacological Therapies for Concussions
Hall, E. D., Park, E., & BAKER, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-93813-0_9 · Cited by 1
Ouerdane, Y., El-Nahas, Z. S., Ouerdane, F., Hamam, K. M., & Ebada, M. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_12 · Cited by 4
Stabilizing Calcium Homeostasis
Mattson, M. P. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_5 · Cited by 1
Self-citationDamme, P. V., Bosch, L. V. D., & Robberecht, W. (2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70111-4 · Cited by 1
Chapter 1 Genetic Contributions to the Pathogenesis of Alzheimer's Disease
Mattson, M. P. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60021-8 · Cited by 1
Self-citation
Metadata
- Authors
- Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P.
- Affiliations
- University of Kentucky (US)
- University of Graz (AT)
- Corresponding author
- Mattson, Mark P.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1997-07
- Volume
- 69
- Issue
- 1
- Pages
- 273-284
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2069303994
- Cited by
- 439
- References
- 0
- Citations by year
- 2025: 3 · 2024: 8 · 2023: 11 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 4 · 2016: 20 · 2015: 10 · 2014: 8 · 2013: 12 · 2012: 15
- FWCI
- 19.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns030583-04)
- National Institute on Aging (P50AG005144, AG-05144, P01AG010836, AG 10836)
- National Institute of Neurological Disorders and Stroke (NS30583)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- amyloid-beta, Alzheimer's disease, 4-hydroxynonenal, lipid peroxidation, glucose transport, glutamate uptake, mitochondrial dysfunction, oxidative stress, synaptosomes, reactive oxygen species, ATP depletion, synaptic degeneration, excitotoxicity, antioxidants, neurodegeneration
- MeSH terms
- Aldehydes, Animals, Biological Transport, Cell Membrane, Cross-Linking Reagents, Energy Metabolism, Female, Glucose, Mitochondria, Synapses, Synaptosomes, Lipid Peroxidation, Amyloid beta-Peptides, Rats, Sprague-Dawley, Reactive Oxygen Species, Oxidative Stress, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review